头颈癌患者的血管事件:系统评价与Meta分析
该系统评价纳入截至2023年4月的146项研究,共1 184 160例头颈癌患者,4.3%发生血管事件。与手术和化疗相比,放疗的总体事件及卒中风险最高;与手术相比,化疗的卒中及总体事件风险更高。数据不支持常规抗凝。
要点
- 头颈癌患者血管事件发生率为4.3%。
- 放疗的总体事件及卒中风险高于手术和化疗。
- 化疗的卒中及总体事件风险高于手术。
核心结论
- 血管事件发生于4%-5%的头颈癌患者。
- 数据不支持常规抗凝。
- 接受放疗的患者事件频率最高。
研究设计与样本
- 系统评价与Meta分析,检索截至2023年4月的原始研究,共纳入146项研究。
主要发现
- 共1 184 160例患者,4.3%发生血管事件。
- 与手术和化疗相比,放疗的总体事件及卒中风险最高。
- 与手术相比,化疗的卒中及总体事件风险更高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the incidence of vascular events in patients with head and neck cancer. REVIEW METHODS: Primary studies identified through April 2023. Meta-analysis was performed. RESULTS: There were 146 studies included in the systematic review. Rates of events were collected in the overall group, those with chemoprophylaxis, and those that underwent surgery, radiation, or chemotherapy. Of 1 184 160 patients, 4.3% had a vascular event. Radiation therapy had highest risk of overall events and stroke when compared to surgery and chemotherapy. Chemotherapy had a higher risk of stroke and overall events when compared to surgery. CONCLUSIONS: Vascular events occur in 4%-5% of patients with head and neck cancer. Our data does not support the use of routine anticoagulation. Patients undergoing radiation therapy had the highest frequency of events.
引用
- Monaghan NP, Duckett KA, Nguyen SA, et al. Vascular events in patients with head and neck cancer: A systematic review and meta-analysis. Head Neck. 2024. PMID: 38334324. doi:10.1002/hed.27675
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。